Invenomic Capital Management’s Zoom ZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-224,688
Closed -$16.6M 201
2025
Q1
$16.6M Sell
224,688
-65,238
-23% -$5.2M 0.84% 37
2024
Q4
$23.7M Sell
289,926
-321,793
-53% -$25.3M 1.13% 20
2024
Q3
$42.7M Sell
611,719
-121,546
-17% -$7.6M 2.34% 5
2024
Q2
$43.4M Buy
733,265
+60,373
+9% +$3.71M 2.11% 8
2024
Q1
$44M Buy
672,892
+92,171
+16% +$6.14M 2.34% 6
2023
Q4
$41.8M Sell
580,721
-133,742
-19% -$8.84M 1.91% 11
2023
Q3
$50M Buy
714,463
+127,504
+22% +$8.85M 2.1% 10
2023
Q2
$39.8M Buy
586,959
+226,832
+63% +$15.2M 2.02% 12
2023
Q1
$26.6M Buy
360,127
+7,795
+2% +$562K 1.5% 19
2022
Q4
$23.9M Buy
352,332
+117,981
+50% +$8.96M 1.62% 16
2022
Q3
$17.2M Buy
+234,351
New +$22.3M 1.48% 21

Other funds holding ZM

Invenomic Capital Management's ZM Position: Q2 2025 in Review

Invenomic Capital Management sold out of Zoom (ZM) in Q2 2025, closing a stake of 224,688 shares — an estimated $16.6M sold.

Invenomic Capital Management first reported a position in ZM in Q3 2022 and held it in 11 quarters. The position peaked at $50M in Q3 2023. 719 funds tracked by Wall St. Rank hold ZM as of Q2 2025.

  • Invenomic Capital Management reported no remaining Zoom position as of Q2 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 224,688 Zoom shares in Q2 2025, an estimated $16.6M.
  • Invenomic Capital Management first reported a position in Zoom in Q3 2022 and held it in 11 quarters.
  • Invenomic Capital Management's Zoom position peaked at $50M in Q3 2023.
  • 719 funds tracked by Wall St. Rank held Zoom as of Q2 2025.

Based on Invenomic Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.